SCHEMBL8375694

SCHEMBL8375694

CC(C)(C)OC(=O)NCCOc1cc(-c2cccc3ccccc23)on1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NQO2 P16083 1/20 0.44
PDK2 Q15119 1/20 0.44
BCHE P06276 3/20 0.42
CNR2 P34972 2/20 0.42
SCN9A Q15858 1/20 0.42
KDM4E B2RXH2 2/20 0.41
ALDH1A1 P00352 2/20 0.41
HPGD P15428 2/20 0.41
RAB9A P51151 1/20 0.40
HSD17B10 Q99714 1/20 0.40
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA9 Q16790 1/20 0.40
CYP1A2 P05177 1/20 0.39
MALT1 Q9UDY8 1/20 0.39
IDO1 P14902 1/20 0.39
KDM4A O75164 1/20 0.38
CYP2D6 P10635 2/20 0.38
CYP1A1 P04798 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8377366 0.87 PDK2 (0.46) PDK2BCHECNR2SCN9AKDM4E
SCHEMBL8377376 0.86 PDK2 (0.46) PDK2BCHECNR2KDM4EALDH1A1
SCHEMBL8377397 0.85 HSD17B10 (0.58) PDK2KDM4EALDH1A1HPGDRAB9A
SCHEMBL8380157 0.84 PDK2 (0.48) PDK2BCHECNR2SCN9AKDM4E
SCHEMBL8374999 0.84 PDK2 (0.44) PDK2SCN9AKDM4EALDH1A1HPGD
SCHEMBL8378941 0.83 GABRA5 (0.46) PDK2BCHECNR2RAB9ACA12
SCHEMBL8375557 0.81 BCHE (0.47) PDK2BCHECNR2CA12CA1
SCHEMBL8376833 0.81 LMNA (0.43) PDK2BCHECNR2SCN9AKDM4E
SCHEMBL8380153 0.79 ACKR3 (0.44) PDK2SCN9ACA12CA1CA2
SCHEMBL8380096 0.79 TP53 (0.57) KDM4EALDH1A1HPGDRAB9ACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6005116-A HAVE INHIBITION ACTIVITIES AGAINST TYPE A-MONOAMINE OXIDASE; TREATING OR PREVENTING DEPRESSION, PARKINSON'S DISEASE, ALZEHEIMER'S DEMENTIA, OR CEREBROVASCULAR DEMENTIA SANKYO COMPANY, LIMITED (JP) 1999-12-21 US disclosed
EP-0885891-A1 ISOXAZOLE DERIVATIVES SANKYO COMPANY LIMITED (JP) 1998-12-23 EP disclosed